Protein tyrosine phosphatase 1B is a regulator of the interleukin-10 - Induced transcriptional program in macrophages

Science Signaling

Volumn 7, Issue 324, 2014, Pages

  Pike, Kelly A ^a   Hutchins, Andrew P ^b,c   Vinette, Valerie ^a,d   Théberge, Jean François ^a   Sabbagh, Laurent ^e   Tremblay, Michel L ^a,d   Miranda Saavedra, Diego ^b,f  

^a MCGILL UNIVERSITY   (Canada)

^b OSAKA UNIVERSITY   (Japan)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTOME; PTPN1 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SURFACE; GENE EXPRESSION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA SEQUENCE; ANIMAL; BIOSYNTHESIS; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; INTERLEUKIN-10; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900566132     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005020     Document Type: Article

References (56)

1. J. E. Darnell Jr., I. M. Kerr, G. R. Stark, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
2. D. E. Levy, J. E. Darnell Jr., STATs: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651-662 (2002).
3. P. J. Murray, S. T. Smale, Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 13, 916-924 (2012).
4. B. A. Croker, D. L. Krebs, J. G. Zhang, S. Wormald, T. A. Willson, E. G. Stanley, L. Robb, C. J. Greenhalgh, I. Förster, B. E. Clausen, N. A. Nicola, D. Metcalf, D. J. Hilton, A. W. Roberts, W. S. Alexander, SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545 (2003).
5. R. Lang, A. L. Pauleau, E. Parganas, Y. Takahashi, J. Mages, J. N. Ihle, R. Rutschman, P. J. Murray, SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546-550 (2003).
6. H. Yasukawa, M. Ohishi, H. Mori, M. Murakami, T. Chinen, D. Aki, T. Hanada, K. Takeda, S. Akira, M. Hoshijima, T. Hirano, K. R. Chien, A. Yoshimura, IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551-556 (2003).
7. A. P. Hutchins, D. Diez, Y. Takahashi, S. Ahmad, R. Jauch, M. L. Tremblay, D. Miranda-Saavedra, Distinct transcriptional regulatory modules underlie STAT3's cell type-independent and cell type-specific functions. Nucleic Acids Res. 41, 2155-2170 (2013).
8. M. Feldhammer, N. Uetani, D. Miranda-Saavedra, M. L. Tremblay, PTP1B: A simple enzyme for a complex world. Crit. Rev. Biochem. Mol. Biol. 48, 430-445 (2013).
9. Y. Nakamura, N. Patrushev, H. Inomata, D. Mehta, N. Urao, H. W. Kim, M. Razvi, V. Kini, K. Mahadev, B. J. Goldstein, R. McKinney, T. Fukai, M. Ushio-Fukai, Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell - cell adhesions in endothelial cells. Circ. Res. 102, 1182-1191 (2008).
10. A. Salmeen, J. N. Andersen, M. P. Myers, N. K. Tonks, D. Barford, Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol. Cell 6, 1401-1412 (2000).
11. M. P. Myers, J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford, N. K. Tonks, TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276, 47771-47774 (2001).
12. I. K. Lund, J. A. Hansen, H. S. Andersen, N. P. Møller, N. Billestrup, Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J. Mol. Endocrinol. 34, 339-351 (2005).
13. P. Sharma, R. Chakraborty, L. Wang, B. Min, M. L. Tremblay, T. Kawahara, J. D. Lambeth, S. J. Haque, Redox regulation of interleukin-4 signaling. Immunity 29, 551-564 (2008).
14. X. Lu, R. Malumbres, B. Shields, X. Jiang, K. A. Sarosiek, Y. Natkunam, T. Tiganis, I. S. Lossos, PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood 112, 4098-4108 (2008).
15. K. M. Heinonen, N. Dubé, A. Bourdeau, W. S. Lapp, M. L. Tremblay, Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 2776-2781 (2006).
16. K. M. Heinonen, A. Bourdeau, K. M. Doody, M. L. Tremblay, Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-γ signaling. Proc. Natl. Acad. Sci. U.S.A. 106, 9368-9372 (2009).
17. S. Berdnikovs, V. I. Pavlov, H. Abdala-Valencia, C. A. McCary, D. J. Klumpp, M. L. Tremblay, J. M. Cook-Mills, PTP1B deficiency exacerbates inflammation and accelerates leukocyte trafficking in vivo. J. Immunol. 188, 874-884 (2012).
18. L. Grant, K. Shearer, A. Czopek, E. Lees, C. Owen, A. Agouni, J. Workman, C. Martin-Granados, J. V. Forrester, H. M. Wilson, N. Mody, M. Delibegovic, Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharide induced inflammation, hyperinsulinemia and endotoxemia through an IL-10 STAT3-dependent mechanism. Diabetes 63, 456-470 (2014).
19. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran, M. J. Gresser, M. L. Tremblay, B. P. Kennedy, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999).
20. E. Carballo, W. S. Lai, P. J. Blackshear, Feedback inhibition of macrophage tumor necrosis factor-a production by tristetraprolin. Science 281, 1001-1005 (1998).
21. H. Kuwata, Y. Watanabe, H. Miyoshi, M. Yamamoto, T. Kaisho, K. Takeda, S. Akira, IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages. Blood 102, 4123-4129 (2003).
22. F. O. Martinez, A. Sica, A. Mantovani, M. Locati, Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008).
23. J. Montalibet, K. Skorey, D. McKay, G. Scapin, E. Asante-Appiah, B. P. Kennedy, Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding. J. Biol. Chem. 281, 5258-5266 (2006).
24. S. G. Julien, N. Dubé, M. Read, J. Penney, M. Paquet, Y. Han, B. P. Kennedy, W. J. Muller, M. L. Tremblay, Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat. Genet. 39, 338-346 (2007).
25. E. Asante-Appiah, S. Patel, C. Desponts, J. M. Taylor, C. Lau, C. Dufresne, M. Therien, R. Friesen, J. W. Becker, Y. Leblanc, B. P. Kennedy, G. Scapin, Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase. J. Biol. Chem. 281, 8010-8015 (2006).
26. K. J. Johnson, A. R. Peck, C. Liu, T. H. Tran, F. E. Utama, A. B. Sjolund, J. D. Schaber, A. K. Witkiewicz, H. Rui, PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. Am. J. Pathol. 177, 2971-2983 (2010).
27. A. P. Hutchins, S. Poulain, D. Miranda-Saavedra, Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood 119, e110-e119 (2012).
28. R. Ostuni, V. Piccolo, I. Barozzi, S. Polletti, A. Termanini, S. Bonifacio, A. Curina, E. Prosperini, S. Ghisletti, G. Natoli, Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157-171 (2013).
29. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, W. Müller, Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
30. R. K. Sellon, S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick, R. B. Sartor, Resident enteric bacteria are necessary for development of spontaneous colitis and immune systemactivation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231 (1998).
31. M. Ejrnaes, C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, M. G. von Herrath, Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203, 2461-2472 (2006).
32. D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, M. B. Oldstone, Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301-1309 (2006).
33. R. T. Gazzinelli, M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kühn, W. Müller, G. Trinchieri, A. Sher, In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798-805 (1996).
34. C. Li, I. Corraliza, J. Langhorne, A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67, 4435-4442 (1999).
35. M. Saraiva, A. O'Garra, The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
36. H. Jiang, Y. Lu, L. Yuan, J. Liu, Regulation of interleukin-10 receptor ubiquitination and stability by beta-TrCP-containing ubiquitin E3 ligase. PLOS One 6, e27464 (2011).
37. T. Yamamoto, Y. Sekine, K. Kashima, A. Kubota, N. Sato, N. Aoki, T. Matsuda, The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun. 297, 811-817 (2002).
38. M. K. Pandey, B. Sung, K. S. Ahn, B. B. Aggarwal, Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol. Pharmacol. 75, 525-533 (2009).
39. A. B. Kunnumakkara, A. S. Nair, B. Sung, M. K. Pandey, B. B. Aggarwal, Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol. Cancer Res. 7, 118-128 (2009).
40. Y. Ke, E. E. Zhang, K. Hagihara, D. Wu, Y. Pang, R. Klein, T. Curran, B. Ranscht, G. S. Feng, Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol. Cell. Biol. 27, 6706-6717 (2007).
41. L. Rousso-Noori, H. Knobler, E. Levy-Apter, Y. Kuperman, A. Neufeld-Cohen, Y. Keshet, V. R. Akepati, R. A. Klinghoffer, A. Chen, A. Elson, Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab. 13, 562-572 (2011).
42. X. Zhang, A. Guo, J. Yu, A. Possemato, Y. Chen, W. Zheng, R. D. Polakiewicz, K. W. Kinzler, B. Vogelstein, V. E. Velculescu, Z. J. Wang, Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proc. Natl. Acad. Sci. U.S.A. 104, 4060-4064 (2007).
43. K. A. Pike, M. L. Tremblay, Regulating naïve and memory CD8 T cell homeostasis - A role for protein tyrosine phosphatases. FEBS J. 280, 432-444 (2013).
44. D. J. Kim, M. L. Tremblay, J. Digiovanni, Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation. PLOS One 5, e10290 (2010).
45. F. Ahmad, B. J. Goldstein, Effect of tumor necrosis factor-α on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific proteintyrosine phosphatases. J. Cell. Biochem. 64, 117-127 (1997).
46. F. Ahmad, R. V. Considine, T. L. Bauer, J. P. Ohannesian, C. C. Marco, B. J. Goldstein, Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 46, 1140-1145 (1997).
47. J. M. Zabolotny, Y. B. Kim, L. A. Welsh, E. E. Kershaw, B. G. Neel, B. B. Kahn, Proteintyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 283, 14230-14241 (2008).
48. J. Zhang, B. Wang, W. Zhang, Y. Wei, Z. Bian, C. Y. Zhang, L. Li, K. Zen, Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells. PLOS One 8, e70828 (2013).
49. C. J. Carbone, H. Zheng, S. Bhattacharya, J. R. Lewis, A. M. Reiter, P. Henthorn, Z. Y. Zhang, D. P. Baker, R. Ukkiramapandian, K. K. Bence, S. Y. Fuchs, Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proc. Natl. Acad. Sci. U.S.A. 109, 19226-19231 (2012).
50. H. Xu, H. An, J. Hou, C. Han, P. Wang, Y. Yu, X. Cao, Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Mol. Immunol. 45, 3545-3552 (2008).
51. B. Li, C. N. Dewey, RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
52. B. Langmead, C. Trapnell, M. Pop, S. L. Salzberg, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
53. D. Risso, K. Schwartz, G. Sherlock, S. Dudoit, GC-content normalization for RNA-Seq data. BMC Bioinformatics 12, 480 (2011).
54. M. D. Robinson, D. J. McCarthy, G. K. Smyth, edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
55. Y. Shen, F. Yue, D. F. McCleary, Z. Ye, L. Edsall, S. Kuan, U. Wagner, J. Dixon, L. Lee, V. V. Lobanenkov, B. Ren, A map of the cis-regulatory sequences in the mouse genome. Nature 488, 116-120 (2012).
56. + T cells. Genomics 100, 303-313 (2012).